AgomAb Therapeutics NV's director David R. Epstein acquires 5,000 shares at $5.57, signaling confidence in the company's future.
| Name | AgomAb Therapeutics NV |
|---|---|
| CIK | 0002020932 |
| Tickers | AGMB |
| Exchanges | Nasdaq |
| Entity type | other |
| Category | Non-accelerated filer<br>Emerging growth company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | C9 Belgium |
| Phone | 32 3 302 35 30 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
AgomAb Therapeutics NV's director David R. Epstein acquires 5,000 shares at $5.57, signaling confidence in the company's future.
AgomAb Therapeutics NV details share transactions by director David R. Epstein, signaling ongoing engagement and confidence in the company's future.
David R. Epstein, director at AgomAb Therapeutics, increases his share ownership in the company, signaling confidence in its future prospects.
AgomAb Therapeutics NV's director, David R. Epstein, acquires 10,000 shares, signaling confidence in the company's future within the biological products sector.
AgomAb Therapeutics NV announces first patient dosing in Phase 2b study of ontunisertib for Fibrostenosing Crohn's disease, marking a key milestone.
AgomAb Therapeutics NV's David R. Epstein buys 5,000 shares, indicating confidence in the company's prospects in the biological products sector.
David R. Epstein, a director at AgomAb Therapeutics, acquires 10,000 shares in recent transactions, signaling confidence in the company's future.
52 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-19 | 4 | PRIMARY DOCUMENT | 0001445826-26-000020 | 4978 | ||||||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000905148-26-004929 | 005-95508 | 261561215 | 34 | 11671 | |||
| 2026-11-16 | 4 | PRIMARY DOCUMENT | 0001445826-26-000019 | 9491 | ||||||
| 2026-11-06 | 4 | PRIMARY DOCUMENT | 0001445826-26-000018 | 7990 | ||||||
| 2026-10-22 | 4 | PRIMARY DOCUMENT | 0001445826-26-000015 | 6483 | ||||||
| 2026-10-13 | 6-K | FORM 6-K | 0001104659-26-115567 | 001-43098 | 261457679 | 34 | 37558 | |||
| 2026-10-09 | 4 | PRIMARY DOCUMENT | 0001445826-26-000014 | 4973 | ||||||
| 2026-10-07 | 4 | PRIMARY DOCUMENT | 0001445826-26-000013 | 6379 | ||||||
| 2026-10-07 | 4 | PRIMARY DOCUMENT | 0002119332-26-000001 | 8162 | ||||||
| 2026-10-07 | 4 | PRIMARY DOCUMENT | 0002120886-26-000001 | 8049 | ||||||
| 2026-10-01 | 6-K | FORM 6-K | 0001104659-26-112564 | 001-43098 | 261428898 | 34 | 60883 | |||
| 2026-09-15 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-107916 | 6348 | ||||||
| 2026-09-15 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-107915 | 6326 | ||||||
| 2026-09-15 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-107914 | 10004 | ||||||
| 2026-09-15 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-107912 | 10167 | ||||||
| 2026-09-14 | 6-K | FORM 6-K | 0001104659-26-107500 | 001-43098 | 261377514 | 34 | 38681 | |||
| 2026-09-11 | 6-K | FORM 6-K | 0001104659-26-107117 | 001-43098 | 261375118 | 34 | 29000 | |||
| 2026-08-10 | 6-K | FORM 6-K | 0001104659-26-093390 | 001-43098 | 261258677 | 34 | 5357703 | |||
| 2026-08-06 | 6-K | 6-K | 0001104659-26-091992 | 001-43098 | 261248896 | 34 | 260460 | |||
| 2026-06-23 | 6-K | FORM 6-K | 0001104659-26-076819 | 001-43098 | 261111177 | 34 | 60801 | |||
| 2026-05-27 | 6-K | FORM 6-K | 0001104659-26-066590 | 001-43098 | 261022150 | 34 | 37258 | |||
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-062718 | 005-95508 | 26989065 | 34 | 12077 | |||
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-002216 | 005-95508 | 26985171 | 34 | 10417 | |||
| 2026-05-06 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-207455 | 005-95508 | 26945590 | 34 | 7487 | |||
| 2026-04-24 | 6-K | FORM 6-K | 0001104659-26-048615 | 001-43098 | 26894425 | 34 | 2880839 | |||
| 2026-04-23 | 20-F | FORM 20-F | 0001104659-26-047872 | 001-43098 | 26889755 | 34 | 20505184 | 1 | 1 | |
| 2026-04-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001213900-26-044365 | 005-95508 | 26865894 | 34 | 20017 | |||
| 2026-03-18 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-030839 | 13432 | ||||||
| 2026-03-18 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-030843 | 24452 | ||||||
| 2026-03-18 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-030838 | 13183 | ||||||
| 2026-03-18 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-030840 | 11490 | ||||||
| 2026-03-18 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-030842 | 14691 | ||||||
| 2026-03-18 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-030841 | 15173 | ||||||
| 2026-03-18 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-030835 | 17281 | ||||||
| 2026-03-18 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-030836 | 11656 | ||||||
| 2026-03-18 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-030834 | 16879 | ||||||
| 2026-03-18 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-030833 | 18096 | ||||||
| 2026-03-18 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-030837 | 22499 | ||||||
| 2026-03-11 | S-8 | FORM S-8 | 0001104659-26-026472 | 333-294220 | 26744546 | 33 | 425014 | 1 | 1 | |
| 2026-03-06 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-26-000646 | 005-95508 | 26728945 | 34 | 11407 | |||
| 2026-03-05 | 6-K | FORM 6-K | 0001104659-26-024095 | 001-43098 | 26726062 | 34 | 130529 | |||
| 2026-02-17 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-26-052946 | 005-95508 | 26636235 | 34 | 138471 | |||
| 2026-02-09 | 6-K | FORM 6-K | 0001104659-26-012080 | 001-43098 | 26611678 | 34 | 177901 | |||
| 2026-02-06 | 424B4 | 424B4 | 0001104659-26-011523 | 333-292790 | 26607819 | 33 | 7604310 | |||
| 2026-02-05 | CERT | AGMB_8A_Cert_0002020932.pdf | 0001354457-26-000141 | 001-43098 | 26601076 | 34 | 124821 | |||
| 2026-02-03 | 8-A12B | FORM 8-A12B | 0001104659-26-009822 | 001-43098 | 26594561 | 34 | 19112 | |||
| 2026-01-30 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000416 | 333-292790 | 26585496 | 33 | 1814 | ||
| 2026-01-29 | F-1/A | F-1/A | 0001104659-26-007712 | 333-292790 | 26574827 | 33 | 8663311 | 1 | 1 | |
| 2026-01-16 | F-1 | F-1 | 0001104659-26-004558 | 333-292790 | 26539714 | 33 | 58288782 | 1 | 1 | |
| 2025-12-17 | DRS/A | filename1.htm | 0001104659-25-122109 | 377-07291 | 251580228 | 33 | 41343155 | |||
| 2025-10-28 | DRS/A | filename1.htm | 0001104659-25-102694 | 377-07291 | 251421067 | 33 | 6309672 | |||
| 2024-06-20 | DRS | filename1.htm | 0001104659-24-073452 | 377-07291 | 241057239 | 33 | 7284634 |
One latest value per concept from companyfacts (1 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 34.17M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-23 | 0001104659-26-047872 |